Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v11-FR
Language English French
Date Updated 2017-05-16 2017-05-09
Drug Identification Number 02022826 02022826
Brand name PDP-AMANTADINE HYDROCHLORIDE SYRUP PDP-AMANTADINE HYDROCHLORIDE SYRUP
Common or Proper name pms-AMANTADINE HCL 10mg/1mL SYRUP 500mL pms-AMANTADINE HCL 10mg/1mL SYRUP 500mL
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients AMANTADINE HYDROCHLORIDE AMANTADINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 500mL 500mL
ATC code N04BB N04BB
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-05-15 2017-05-15
Actual start date
Estimated end date 2017-05-24 2017-05-24
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments